The prevalence of nonalcoholic steatohepatitis (NASH), a progressive type of fatty liver disease, appears to be on the rise in adolescents, increasing four-fold between 1988 and 2010, according to...

Particular eating behaviors may lower the risk of developing non-alcoholic fatty liver disease (NAFLD), according to research presented this week at The Liver Meeting® — held by the American...

UCB, a global biopharmaceutical company focusing on immunology, neurology and bone treatments and research, is proud to announce 16 CIMZIA® (certolizumab pegol) presentations at the 2016 American...

Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases and...

Trimble (NASDAQ: TRMB) concluded its 8th International User Conference with more than 4,400 registered attendees representing over 80 countries. Dimensions 2016 provided insight into how...

VolitionRx Limited (NYSE MKT: VNRX) today announced that it will present at the Canaccord Genuity Medical Technologies & Diagnostics Forum 2016 being held on November 17, 2016 in New York, NY....

Beyond Screen Limited today announced that it has been named a CES 2017 Innovation Awards Honoree for its Beyond Tablet product. Products entered in this prestigious program are judged by a...

DalCor Pharmaceuticals today announced the key investigator in dalcetrapib trials, Jean-Claude Tardif, C.M., M.D., FRCPC, FACC, FAHA, FESC, will present data at the American Heart Association...

Tata Capital from India and a UN Women campaign from Egypt are the 2016 winners of the EthicMark® Awards for advertising and media campaigns that "uplift the human spirit and society."...

Just days after an unprecedented 8 states passed medical or recreational marijuana initiatives, all of the nascent industry's key players will gather at Marijuana Business Daily's 5th Annual...